Press releases|17 November 2025 Global law firm Hogan Lovells is advising Togus Urban Renewal, LLC, in its development of 1888 Studios, an industry-leading film and television production studio in Bayonne,
Press releases|17 November 2025 Global law firm Hogan Lovells is advising Togus Urban Renewal, LLC, in its development of 1888 Studios, an industry-leading film and television production studio in Bayonne,
Press releases|12 November 2025 12 November 2025 – Global law firm Hogan Lovells has advised Di Carlo Holdings (“DCH”), a group active in the renewable energy sector with a focus
Baker McKenzie Switzerland acted as Swiss counsel to Schulthess Maschinen AG in relation to the Swiss legal aspects of financing its acquisition of Armstrong France SAS, a leader in the
Linklaters advised The Hongkong and Shanghai Banking Corporation Limited (HSBC) on the launch of its Tokenised Deposit Service (TDS) in Singapore, marking a significant milestone in the bank’s expansion of
DLA Piper has represented South Africa’s leading banks in the acquisition by the South African Reserve Bank (SARB), Capitec Bank and Investec Bank of shares in the South African Bankers
Linklaters has advised PCC Global Plc (Paragon), a global provider of business services, on its debut high yield issuance of €450 million senior secured notes due 2030 and €135 million
November 20, 2025 Dusseldorf—Global law firm Dentons has advised UniCredit as documentation agent on a US$1.1 billion revolving credit facility with a borrowing base reference for Neumann Gruppe GmbH. UniCredit
Baker McKenzie advised CARBOGEN AMCIS AG (“Carbogen Amcis”) on its successful refinancing and enhancement of its credit facilities through a banking syndicate led by UBS Switzerland AG with the participation
4D Molecular Therapeutics (Nasdaq: FDMT), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, has announced the
Linklaters has advised Sandoz, the global leader in affordable medicines, on the strategic agreement with Evotec SE to acquire all issued and outstanding equity interests of Just-Evotec Biologics EU SAS